Kestra Medical Technologies, Ltd. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Kestra Medical Technologies, Ltd. (KMTS) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$4.73 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-07-31 was -$4.73M.
- Kestra Medical Technologies, Ltd. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-04-30 was $4.00M, a 112.24% increase year-over-year.
- Kestra Medical Technologies, Ltd. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-01-31 was $3.67M, a 288.98% increase year-over-year.
- Kestra Medical Technologies, Ltd. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-10-31 was $1.38M, a 16.16% decline year-over-year.
- Kestra Medical Technologies, Ltd. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2026 was $8.20M, a 77.54% increase from fiscal 2025.
- Kestra Medical Technologies, Ltd. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $4.62M, a 1144.47% increase from fiscal 2024.
- Kestra Medical Technologies, Ltd. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $371.00K.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-07-31 | -$4.73M 10-Q · filed 2026-09-14 | -$722.00K derived: sum of 2 quarters · filed 2026-09-14 | $2.95M derived: sum of 3 quarters · filed 2026-09-14 | $4.33M derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $7.68M derived: sum of 2 quarters · filed 2026-07-14 | $9.06M derived: sum of 3 quarters · filed 2026-07-14 | $8.20M 10-K · filed 2026-07-14 |
| 2026-01-31 | $3.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | $5.05M derived: sum of 2 quarters · filed 2026-03-17 | $4.19M 10-Q · filed 2026-03-17 | $6.08M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-11 | $520.00K 10-Q · filed 2025-12-11 | $2.41M derived: sum of 3 quarters · filed 2026-09-14 | $3.35M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | -$860.00K 10-Q · filed 2026-09-14 | $1.03M derived: sum of 2 quarters · filed 2026-09-14 | $1.97M derived: sum of 3 quarters · filed 2026-09-14 | $3.62M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $2.83M derived: sum of 2 quarters · filed 2026-07-14 | $4.48M derived: sum of 3 quarters · filed 2026-07-14 | $4.62M 10-K · filed 2026-07-14 |
| 2025-01-31 | $944.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | $2.59M derived: sum of 2 quarters · filed 2026-03-17 | $2.73M 10-Q · filed 2026-03-17 | |
| 2024-10-31 | $1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-11 | $1.79M 10-Q · filed 2025-12-11 | ||
| 2024-07-31 | $140.00K 10-Q · filed 2025-09-12 | |||
| 2024-04-30 | $371.00K 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |